IS7449A - Afleiður 9-dexó-9a-asa-9a-metýl-9a-hómóerýþrómýsíns A - Google Patents

Afleiður 9-dexó-9a-asa-9a-metýl-9a-hómóerýþrómýsíns A

Info

Publication number
IS7449A
IS7449A IS7449A IS7449A IS7449A IS 7449 A IS7449 A IS 7449A IS 7449 A IS7449 A IS 7449A IS 7449 A IS7449 A IS 7449A IS 7449 A IS7449 A IS 7449A
Authority
IS
Iceland
Prior art keywords
aza
methyl
homoerodymycin
dexo
derivatives
Prior art date
Application number
IS7449A
Other languages
English (en)
Inventor
Dumic Miljenko
Vinkovic Mladen
Oresic Marina
Mestrovic Ernest
Danilovski Aleksandar
Dumbovic Alojz
Knezevic Zdravka
Lazarevski Gorjana
Cincic Dominik
Filic Darko
Lazaric Katica
Bucar Dejan-Kresimir
Original Assignee
Pliva - Istrazivanje I Razvoj D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva - Istrazivanje I Razvoj D.O.O. filed Critical Pliva - Istrazivanje I Razvoj D.O.O.
Publication of IS7449A publication Critical patent/IS7449A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Finger-Pressure Massage (AREA)
  • Instructional Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
IS7449A 2002-03-18 2004-09-16 Afleiður 9-dexó-9a-asa-9a-metýl-9a-hómóerýþrómýsíns A IS7449A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HR20020231A HRP20020231A2 (en) 2002-03-18 2002-03-18 ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US39361202P 2002-07-03 2002-07-03
US39470502P 2002-07-08 2002-07-08
PCT/IB2003/000987 WO2003077830A2 (en) 2002-03-18 2003-03-18 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives

Publications (1)

Publication Number Publication Date
IS7449A true IS7449A (is) 2004-09-16

Family

ID=28045976

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7449A IS7449A (is) 2002-03-18 2004-09-16 Afleiður 9-dexó-9a-asa-9a-metýl-9a-hómóerýþrómýsíns A

Country Status (23)

Country Link
US (1) US7569549B2 (is)
EP (2) EP1485393B1 (is)
JP (1) JP2005529082A (is)
KR (1) KR20050002872A (is)
CN (1) CN1642966A (is)
AT (1) ATE440104T1 (is)
AU (1) AU2003215779A1 (is)
BG (1) BG108874A (is)
BR (1) BR0308644A (is)
CA (1) CA2479211A1 (is)
DE (1) DE60328872D1 (is)
EA (1) EA200401217A1 (is)
ES (1) ES2331733T3 (is)
HR (2) HRP20020231A2 (is)
IL (1) IL163836A0 (is)
IS (1) IS7449A (is)
MX (1) MXPA04009009A (is)
NO (1) NO20044341L (is)
NZ (1) NZ535477A (is)
PL (1) PL372468A1 (is)
RS (1) RS82504A (is)
TN (1) TNSN04166A1 (is)
WO (1) WO2003077830A2 (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
WO2005009447A1 (en) * 2003-07-24 2005-02-03 Pliva - Research And Development Ltd. Single dose fast dissolving azithromycin
EP1878432A1 (en) * 2003-07-24 2008-01-16 Pliva - Research and Development Ltd. Single dose fast dissolving azithromycin
ES2308274T3 (es) * 2003-12-04 2008-12-01 Pfizer Products Inc. Procedimiento para fabricar multiparticulados farmaceuticos.
EP1689368B1 (en) * 2003-12-04 2016-09-28 Bend Research, Inc Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547597A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
CA2162401C (en) 1993-05-19 1998-11-03 Bingwei V. Yang Intermediate for azithromycin
HRP940251B1 (en) 1994-04-15 1998-12-31 Stjepan Mutak Process for the preparation of azithromycin dihydrochloride
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102130A (pt) 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CN1205338A (zh) 1998-05-08 1999-01-20 刘万忠 阿奇霉素水溶性盐的合成新方法及其在医药上的用途
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
IL143376A0 (en) * 1998-11-30 2002-04-21 Teva Pharma Ethanolate of azithromycin, process for the manufacture, and pharmaceutical compositions thereof
HRP20010956B1 (hr) * 1999-06-29 2010-09-30 Biochemie S.A. Makrolidi
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
IL150564A0 (en) 2000-01-04 2003-02-12 Teva Pharma Preparation method of azithromycin dihydrate
ES2162764B1 (es) * 2000-05-17 2003-04-01 Ercros Ind Sa Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
AU2000270425A1 (en) 2000-07-25 2002-02-13 Instituto De Investigacion En Quimica Aplicada S.C Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydr oxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin
AU2001280000A1 (en) * 2000-08-23 2002-03-04 Jaweed Mukarram, Siddiqui Mohammed Process for preparation of anhydrous azithromycin
SK287814B6 (sk) 2000-11-27 2011-11-04 Sandoz Ag Azithromycin in the form of a monohydrate, a process for its preparation and pharmaceutical compositions comprising same
KR100491183B1 (ko) 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
KR100431431B1 (ko) 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
SK14402003A3 (sk) 2001-05-22 2004-06-08 Pfizer Products Inc. Kryštalické formy azitromycínu
EP1455758A1 (en) 2001-12-21 2004-09-15 Pfizer Products Inc. Directly compressible formulations of azithromycin
IL161259A0 (en) 2001-12-21 2004-09-27 Pfizer Prod Inc Methods for wet granulating azithromycin
PL372394A1 (en) 2002-02-01 2005-07-25 Pfizer Products Inc. Dry granulated formulations of azithromycin
ITMI20021209A1 (it) 2002-06-04 2003-12-04 Chemi Spa Processo di preparazione di azitromicina ad elevata purezza

Also Published As

Publication number Publication date
JP2005529082A (ja) 2005-09-29
RS82504A (sr) 2006-12-15
HRP20020231A2 (en) 2003-12-31
BR0308644A (pt) 2005-01-25
EP1627883A1 (en) 2006-02-22
TNSN04166A1 (en) 2007-03-12
IL163836A0 (en) 2005-12-18
MXPA04009009A (es) 2005-06-17
EP1485393A2 (en) 2004-12-15
KR20050002872A (ko) 2005-01-10
US7569549B2 (en) 2009-08-04
NZ535477A (en) 2006-11-30
HRP20040858A2 (en) 2005-06-30
AU2003215779A1 (en) 2003-09-29
US20040014951A1 (en) 2004-01-22
EP1485393B1 (en) 2009-08-19
NO20044341L (no) 2004-11-23
DE60328872D1 (en) 2009-10-01
CA2479211A1 (en) 2003-09-25
BG108874A (en) 2005-12-30
CN1642966A (zh) 2005-07-20
WO2003077830A2 (en) 2003-09-25
WO2003077830A3 (en) 2004-05-13
ATE440104T1 (de) 2009-09-15
PL372468A1 (en) 2005-07-25
EA200401217A1 (ru) 2005-02-24
ES2331733T3 (es) 2010-01-14

Similar Documents

Publication Publication Date Title
ATE440104T1 (de) 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivaten
EP1505061A4 (en) CONNECTION WITH PGD-2 RECEPTOR ANTAGONISM
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
CO5280078A1 (es) Compuestos
NO20050065L (no) Kjemiske forbindelser
WO1998028282A3 (en) OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
NO20054195D0 (no) Isoksazolforbindelser som inhibitorer for varmesjokkproteiner
NO20034660D0 (no) Spiropyrazolforbindelser
CY1110000T1 (el) Ενωσεις οκταϋδροβενζιμιδαζολονης ως αναλγητικα
NO20044995L (no) Heterosykliske forbindelser
EP1163910A4 (en) PREVENTIVE / MEDICINE AGAINST INTERSTITIAL PNEUMONIA AND PULMONAL FIBROSIS
ATE477256T1 (de) Thienylverbindungen
WO2007014054A3 (en) Benzenesulfonamide inhibitor of ccr2 chemokine receptor
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
WO2005020293A3 (en) Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
NO20054787L (no) Indenderivater som farmasotiske midler
WO2003053971A8 (en) Pyridoquinoxaline antivirals
SE9904765D0 (sv) Pharmaceutically-useful compounds
SE0100326D0 (sv) New compounds
DE60015390D1 (de) Antidiabetische thiazolidindione und ihre herstellung
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
IL190024A0 (en) Stabilized protease composition
BR0115996A (pt) Sulfamidotienopirimidinas